Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kulshrestha V, Balani S, Kachhawa G, Vanamail P, Kumari R, Sharma J
. Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2021; 260:42-47.
DOI: 10.1016/j.ejogrb.2021.02.017.
View
2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C
. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71.
PMC: 8005924.
DOI: 10.1136/bmj.n71.
View
3.
Zhang Y, Wang Z, Liu B, Cai J
. Pregnancy outcome of overweight and obese Chinese women with gestational diabetes. J Obstet Gynaecol. 2014; 34(8):662-5.
DOI: 10.3109/01443615.2014.920787.
View
4.
Laitinen K, Poussa T, Isolauri E
. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr. 2008; 101(11):1679-87.
DOI: 10.1017/S0007114508111461.
View
5.
Lubin V, Shojai R, Darmon P, Cosson E
. A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin. Diabetes Metab. 2016; 42(3):192-5.
DOI: 10.1016/j.diabet.2016.01.005.
View